Immunoenhancement to prevent nosocomial coagulase-negative staphylococcal sepsis in very low-birth-weight infants

Clinics in Perinatology

Volumn 31, Issue 1, 2004, Pages 69-75

  Devlin, Lori A ^a   Lassiter, Herbert A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BSYX A110; COAGULASE; MONOCLONAL ANTIBODY; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY RESPONSE; ANTIBODY TITER; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; GENETIC ENGINEERING; HUMAN; HYPOGAMMAGLOBULINEMIA; INFECTION PREVENTION; MEDICAL SPECIALIST; NEWBORN; PRIORITY JOURNAL; REVIEW; SEPSIS; SPECIES INVASION; VERY LOW BIRTH WEIGHT;

ADJUVANTS, IMMUNOLOGIC; COAGULASE; CROSS INFECTION; HUMANS; INCIDENCE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 2942556982     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2004.03.010     Document Type: Review

References (22)

1. Polin R.A., Saiman L. Nosocomial infections in the neonatal intensive care unit. NeoReviews. 4:2003;e81-e88
2. Freeman J., Epstein M.F., Smith N.E., Platt R., Sidebottom D.G., Goldmann D.A. Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. Am J Dis Child. 144:1990;324-329
3. Gray J.E., Richardson D.K., McCormick M.C., Goldmann D.A. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics. 95:1995;225-230
4. Sohn A.H., Garrett D.O., Sinkowitz-Cochran R.L., Grohskopf L.A., Levine G.L., Stover B.H., et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr. 139:2001;821-827
5. Shinefield H.R., St.Geme J.W. III Staphylococcal infections. Remington J.S., Klein J.O. Infectious diseases of the fetus and newborn infant. 2001;1217-1247 W.B. Saunders, Philadelphia
6. Kengatharan K.M., De Kimpe S., Robson C., Foster S.J., Thiemermann C. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med. 188:1998;305-315
7. Middelveld R.J., Alving K. Synergistic septicemic action of the gram-positive bacterial cell wall components peptidoglycan and lipoteichoic acid in the pig in vivo. Shock. 13:2000;297-306
8. Wang J.E., Jorgensen P.F., Almlof M., Thiemermann C., Foster S.J., Aasen A.O., et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun. 68:2000;3965-3970
9. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis. 2:2002;171-179
10. Rubin L.G., Sanchez P.J., Siegel J., Levine G., Saiman L., Jarvis W.R. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices [serial online]. Pediatrics. 110:2002;e42. Available at: http://home.mdconsult.com/das/journal/view. Accessed April 23, 2004
11. Lewis D.B., Wilson C.B. Developmental immunology and role of host defenses in neonatal susceptibility to infection. Remington J.S., Klein J.O. Infectious diseases of the fetus and newborn infant. 2001;25-138 W. B. Saunders, Philadelphia
12. Ohlsson A., Lacy J.B. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev. 2:2001;CD000361
13. Weisman L.E., Wilson S.R., Fischer G.W. Intravenous immunoglobulin (IVIG) lots used in clinical trials to prevent late-onset infection in the high risk neonate contained variable Staphylococcus Epidermidis antibody activity. Pediatr Res. 39:1996;304A
14. Cole C.W., Feldhoff R.C., Goldsmith L.J., Jung E., Wilson R.A., Lassiter H.A. Nonspecific human IgG reduces survival in neonatal rats infected with Escherichia coli. Am J Med Sci. 322:2001;141-144
15. Bloom B.T., Kuser T.J., Oelberg D.G., Bifano E.M., White R.D., Schelonka R.L., et al. A phase I, multicenter study of safety and tolerance of a donor-selected staphylococcal immune globulin in very low birth weight infants. Pediatr Res. 53:2004;316A
16. Schibler K. Leukocyte development and disorders during the neonatal period. Christensen R.D. Hematologic problems of the neonate. 2000;311-342 W.B. Saunders, Philadelphia
17. Suri M., Harrison L., Van de Ven C., Cairo M.S. Immunotherapy in the prophylaxis and treatment of neonatal sepsis. Curr Opin Pediatr. 15:2003;155-160
18. Bernstein H.M., Pollock B.H., Calhoun D.A., Christensen R.D. Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: a meta-analysis. J Pediatr. 138:2001;917-920
19. Cairo M.S., Agosti J., Ellis R., Laver J.J., Puppala B., deLemos R., et al. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr. 134:1999;64-70
20. Weisman L.E., Schuman R.F., Lukomska E., Stinson J.R., Parks O., Fischer G.W. Effectiveness and pharmacokinetics of an anti-lipoteichoic acid humanized mouse chimeric monoclonal antibody. Pediatr Res. 49:2001;301A
21. Weisman L.E., Fischer G.W., Mandy G.T., Thackery H., Johnson K.E., Krayer B.D., et al. Safety and pharmacokinetics of an anti-lipoteichoic acid humanized mouse chimeric monoclonal antibody in healthy adults. Pediatr Res. 51:2002;270A
22. Weisman L.E., Mandy G.T., Garcia-Prats J.A., Nesin M., Schneider J.H., Johnson K.E., et al. Safety and pharmacokinetics of a human chimeric anti-staphylococcal monoclonal antibody for prevention of coagulase negative staphylococcal infection in very low birth weight infants: preliminary report. Pediatr Res. 53:2003;315A